The endocannabinoid system and its therapeutic exploitation
The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.
Abstract
The term 'endocannabinoid' - originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands - now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The obvious implications are that cannabinoids and similarly acting drugs may regulate cognitive functions, modulate food intake, affect both female and male reproduction, provide neuroprotection and be involved in neurodegenerative diseases; pathophysiology of shock; inhibition of fertilized oocyte implantation; inhibition of cancer growth, angiogenesis and metastasis (for a review see ref. 71).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [71]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 1×
“∆(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A Neuropsychopharmacology 24, 198–203 (2001).”
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · cited 1×
“The serendipitous cloning in 1990 of the first of such proteins, the CB 1 receptor, came from the screening of an 'orphan' G-protein-coupled receptor (GPCR) with several possible ligand”
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), led to the identification of plasma membrane CANNABINOID RECEPTORS in 1988 (Ref”
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 1×
“Functions of the endocannabinoid system The components ( Figs 3 , 4 ) and possible physiological functions of the endocannabinoid system have been extensively reviewed in recent article”
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Research works printed but not linked: 4
- Mechoulam, R. in Cannabis as Therapeutic Agent (ed. Mechoulam, R.) 1–19 (CRC Press Roca Ranton, 1986). The most comprehensive history of the recreational and medicinal use of Cannabis throughout the centuries.
- Di Marzo, V., Bisogno, T., De Petrocellis, L., Berger, A. & Mechoulam, R. in Biology of Marijuana (ed. Onaivi, E.) 125–173 (Harwood Academic, Reading, 2002).
- Pertwee, R. G. in Cannabinoids (ed. Di Marzo, V.) 32–83 (Kluwer Academic, New York, 2004).
- Pop, E. Dexanabinol Pharmos. Curr. Opin. Investig. Drugs 1, 494–503 (2000).
Cited by
Items 701–800 of 1,001
Nayak, A. P., Loblundo, C., & Bielory, L. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.10.009 · Cited by 12
Liu, H., Gao, X. H., Duan, R.-X., Yang, Q., Zhang, Y., Cheng, Y.-W., Guo, Y., & Tang, W.-X. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0209-y · Cited by 12
Thewke, D. P., Dyke, C. N.-V., Rodgers, W., Fulmer, M. L., & Lahr, Z. (2015) · Journal of Cardiology and Therapeutics · doi:10.12970/2311-052x.2015.03.02.2 · Cited by 12
Zhao, X., Liang, P., Liu, J., Jiang, H., Fan, X., Chen, G., & Zhou, C. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5222 · Cited by 12
“As lipid mediators, endocannabinoids are known to be involved in a variety of physiological and pathological process, including protection of the cardiovascular system, depression and various inflammatory responses (1-3).”
BackgroundMizera, M., Latek, D., & Cielecka‐Piontek, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155308 · Cited by 12
“Activation of the CB1 receptor, which is expressed mainly in the central nervous system, is responsible for their psychotropic action, while CB2 receptors are found mainly in the immune system [13].”
BackgroundLeal, E. C., Moura, L. I. F., Pirzgalska, R. M., Marques‐da‐Silva, D., Ledent, C. A., Köfalvi, A., & Carvalho, E. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111528 · Cited by 12
Silva, M. H. (2021) · Current Research in Toxicology · doi:10.1016/j.crtox.2021.08.002 · Cited by 12
“When pathogenic bacteria predominate (Cani et al., 2014; Levy et al., 2017), the eCB system is activated in the gut, along with increases in CB1 receptors, while FAAH is downregulated (Di Marzo, 2008b; DiPatrizio, 2016; Matias and Di Marzo, 2007).”
BackgroundInfluentialLin, Y., Shia, K., Hsiao, W., Hsieh, W.-P., Yeh, T., Tseng, S.-L., Hsu, C., Chao, Y., & Hung, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.06.001 · Cited by 12
“CB1 receptors are present in large numbers in the brain, where they function to inhibit neurotransmitter release [8].”
BackgroundPET Imaging of Endocannabinoid System
Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 12
Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression
Liu, G.-L., Cui, Y., Lu, C., & Zhao, P. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109006 · Cited by 12
Tai, C.-L., Hung, M., Pawar, V. D., Tseng, S.-L., Song, J., Hsieh, W.-P., Chiu, H.-H., Wu, H.-C., Hsieh, M., Kuo, C., et al. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b716434c · Cited by 12
Parkkari, T., Savinainen, J. R., Raitio, K. H., Saario, S. M., Matilainen, L., Sirviö, T., Laitinen, J. T., Nevalainen, T., Niemi, R., & Järvinen, T. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.051 · Cited by 12
The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk
Ginsberg, H. N., & Woods, S. C. (2009) · Obesity · doi:10.1038/oby.2009.107 · Cited by 12
Endocannabinoid System and Cardiometabolic Risk
Saavedra, L. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100373 · Cited by 12
“quent use, endocannabinoids are generated and secreted locally, in proximity to CB1 receptors, on demand and are rapidly degraded and metabolized by specific enzyme groups.(23,24) Activation of CB1 receptors in the central nervous system increases appetite and drives motivation for food ingestion.”
BackgroundMedicinal Cannabis: an overview for health-care providers
Wallach, J. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00005-2 · Cited by 11
Sanluca, C., Spagnolo, P., Mancinelli, R., Bartolo, M. I. D., Fava, M., Maccarrone, M., Carotti, S., Gaudio, E., Leuti, A., & Vivacqua, G. (2024) · Metabolites · doi:10.3390/metabo14070352 · Cited by 11
“Endocannabinoids are a group of lipid mediators that act as endogenous ligands to those receptors that are engaged by the psychoactive constituents of Cannabis sativa and Cannabis indica and have been both characterised as important neuromodulatory and immunomodulatory agents [126].”
BackgroundFin, L., Bergamin, G., Steiner, R. A., & Hughes, S. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05017-5 · Cited by 11
Hamilton, A. J., Payne, A., Mocerino, M., & Gunosewoyo, H. (2021) · Australian journal of chemistry (Print) · doi:10.1071/ch21007 · Cited by 5
Graziano, G., Delre, P., Carofiglio, F., Brea, J. M., Ligresti, A., Kostrzewa, M., Riganti, C., Gioé-Gallo, C., Majellaro, M., Nicolotti, O., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115109 · Cited by 11
Endocannabinoid system and epigenetics in spermatogenesis and testicular cancer
Barchi, M., Guida, E., Dolci, S., Rossi, P., & Grimaldi, P. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.01.002 · Cited by 11
Bandres‐Meriz, J., Kunz, C., Havelund, J. F., Færgeman, N. J., Majali‐Martinez, A., Ensenauer, R. E., & Desoyé, G. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01295-4 · Cited by 11
“As an alternative explanation, N-acetylethanolamides are endogenously synthesised and their concentration is regulated by synthesizing and degrading enzymes such as N-acyl phosphatidyl ethanolamine-specific phospholipase D (NAPE-PLD) and fatty acid amide hydrolase (FAAH) [51].”
BackgroundEffect of antiobesity medications in patients with type 2 diabetes mellitus
Choussein, S., Makri, A., Frangos, C. C., Petridou, E. T., & Daskalopoulou, S. S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01026.x · Cited by 11
Xu, X., Jiang, S., Xu, E., Wu, X., & Zhao, R. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.024 · Cited by 11
Patient Perception Regarding Potential Effectiveness of Cannabis for Pain Management
Jennings, J. M., Johnson, R. M., Brady, A. C., & Dennis, D. A. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.06.051 · Cited by 11
McElroy, D. L., Roebuck, A. J., Greba, Q., Garai, S., Brandt, A. L., Yilmaz, O., Cain, S. M., Snutch, T. P., Thakur, G. A., Laprairie, R. B., et al. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.01.006 · Cited by 11
A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity
Magrioti, V., Naxakis, G., Hadjipavlou‐Litina, D., Makriyannis, A., & Kokotos, G. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.039 · Cited by 11
Scheen, A. J., & Gaal, L. F. V. (2007) · PubMed · Cited by 11
Negative symptoms as key features of depression among cannabis users: a preliminary report.
Bersani, G., Bersani, F. S., Caroti, E., Russo, P. A., Albano, G., Valeriani, G., Imperatori, C., Minichino, A., Manuali, G., & Corazza, O. (2016) · PubMed · Cited by 11
Endocytose et voie de signalisation Notch
Brou, C., & Logeat, F. (2006) · médecine/sciences · doi:10.1051/medsci/20062289685 · Cited by 11
Hansen, H. S., Petersen, G. L., Artmann, A., & Madsen, A. N. (2006) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200600157 · Cited by 11
Giri, M. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.048 · Cited by 5
“The Endocannabinoid system is a neuromodulatory system that plays a role in many physiological processes, including the regulation of food intake and energy homeostasis (40).”
BackgroundIzzo, A. A., & Capasso, F. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.002 · Cited by 11
Emerging medications and pharmacological treatment approaches for substance use disorders
Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 10
“The endocannabinoid system comprises cannabinoid type-1 and type-2 receptors (CB 1 R and CB 2 R), together with their endogenous ligands (endocannabinoids), and the enzymes responsible for their synthesis, reuptake, and degradation (Marzo et al., 2004).”
Zeng, F., Wade, A., Harbert, K., Patel, S., Holley, J. S., Dehghanpuor, C. K., Hopwood, T. W., Marino, S., Sophocleous, A., & Idris, A. I. (2024) · Scientific Reports · doi:10.1038/s41598-024-56220-0 · Cited by 10
Thapa, D., Patil, M., Warne, L. N., Carlessi, R., & Falasca, M. (2025) · Pharmaceuticals · doi:10.3390/ph18020148 · Cited by 10
Bakali, E., Mbaki, Y., Lambert, D. G., Elliott, R. A., Mason, R. J., & Tincello, D. G. (2016) · International Urogynecology Journal · doi:10.1007/s00192-016-2984-x · Cited by 10
“The mechanism by which cannabinoid receptors modulate the micturition reflex is their presence in afferent nerve fibre endings located in the suburothelial layer, which is supported by in vitro studies using CB1 or CB2 receptor agonists; studies using CB1 receptor agonists show they reduce neuronal activity [17] and a…”
BackgroundAdejumo, A., Ajayi, T. O., Adegbala, O. M., & Bukong, T. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001382 · Cited by 10
Yu, J. Q., Ren, L., Su, M., Lv, F., Luo, J., Li, P., & Zhang, Y. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113917 · Cited by 10
Endocannabinoids Promote Hepatic Lipogenesis and Steatosis Through CB1 Receptors
Schwabe, R. F. (2005) · Hepatology · doi:10.1002/hep.20900 · Cited by 10
The endocannabinoid system:A new approach to control cardiovascular disease
Cannon, C. P. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80064-x · Cited by 10
Chen, J.-Z., Myint, K.-Z., & Xie, X. (2011) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2011.569948 · Cited by 10
“Potential therapeutic implications in regulating disease make cannabinoid receptors important GPCR targets for new drug discovery [14].”
BackgroundZendehdel, M., Tirgari, F., Shohre, B., Deldar, H., & Hassanpour, S. (2017) · Brazilian Journal of Poultry Science · doi:10.1590/1806-9061-2016-0438 · Cited by 10
“These results were in agreement with observation in rats (Di Marzo et al., 2004), broilers (Jonaidi et al., 2002), turkeys (Denbow, 1991) sheep (Seone et al., 1984) and pigs (Baldwin et al., 1990).”
BackgroundResultCannabinoïdes de synthèse : aspects pharmacologiques
Alvarez, J., Pape, E., Grassin‐Delyle, S., & Knapp, A. (2014) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2014.09.054 · Cited by 10
Synthesis of a potential photoactivatable anandamide analog
Balas, L., Cascio, M. G., Marzo, V. D., & Durand, T. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.059 · Cited by 10
Self-citationFiner, N., & Pagotto, U. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050030201 · Cited by 10
The Power of Movement: How Exercise Influences Chemotherapy-Induced Peripheral Neuropathy
Loureiro, J. A., Costa‐Pereira, J. T., Pozza, D. H., & Tavares, I. (2025) · Biomedicines · doi:10.3390/biomedicines13051103 · Cited by 9
Dalle, S., & Dalle, S. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101342 · Cited by 9
Aging-Related Mechanisms Underlying Carcinogenesis: Therapeutic Opportunities
Guijarro, A. I., Allavena, G., Pisciotta, L., Nencioni, A., & Caffa, I. (2025) · Aging and Disease · doi:10.14336/ad.2025.0861 · Cited by 9
Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential
Grotsch, K., & Fokin, V. V. (2022) · ACS Central Science · doi:10.1021/acscentsci.1c01100 · Cited by 9
Morales, P., Alba, R. G., & Marichal‐Cancino, B. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00024-6 · Cited by 9
Bouma, J., Broekhuis, J. D., van der Horst, C., Kumar, P., Ligresti, A., van der Stelt, M., & Heitman, L. H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115924 · Cited by 9
Khan, A., Richardson, B., Roeder, N. M., Hamilton, J., Marion, M., Fearby, N. L., White, O., Owada, Y., Kagawa, Y., & Thanos, P. K. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137862 · Cited by 9
Solano-Orrala, D., Silva-Cullishpuma, D. A., Díaz-Cruces, E., Gómez‐López, V. M., Toro‐Mendoza, J., d’Ayala, G. G., Troconis, J., Narváez‐Muñoz, C., Alexis, F., Mercader‐Ros, M. T., et al. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01402 · Cited by 9
Associations of variants of CNR1 with obesity and obesity-related traits in Chinese women
Zhuang, M., Yang, Y., Cao, F., Lü, M., Wang, X., Zhang, J., Chen, X., Cheng, P., Zhang, N., Ye, W., et al. (2012) · Gene · doi:10.1016/j.gene.2011.12.037 · Cited by 9
Maudsley, S. R., Martin, B., & Egan, J. M. (2011) · Endocrinology · doi:10.1210/en.2011-1615 · Cited by 9
Cannabinoids activate the insulin pathway to modulate mobilization of cholesterol in C. elegans
Cravero, B. H., Gallino, S., Florman, J., Vranych, C. V., Diaz, P., Elgoyhen, A. B., Alkema, M. J., & de Mendoza, D. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010346 · Cited by 9
“The endogenous cannabinoid 2-AG and AEA are synthesized within the brain and CNS [44].”
BackgroundPalmitoylethanolamide, adipocytes and obesity-related inflammatory states
Hoareau, L., & Roche, R. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.01.002 · Cited by 9
Schaffer, P. C., Kulkarni, P. M., Janero, D. R., & Thakur, G. A. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115727 · Cited by 9
Hunter, E., Stander, M. A., Koßmann, J., Chakraborty, S., Prince, S., Peters, S. W., & Loedolff, B. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05372-z · Cited by 9
Sophocleous, A., Yiallourides, M., Zeng, F., Pantelas, P., Stylianou, E., Li, B., Carrasco, G., & Idris, A. I. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105928 · Cited by 9
Regulation of subthalamic neuron activity by endocannabinoids
Morera‐Herreras, T., Ruíz-Ortega, J. Á., Taupignon, A., Baufreton, J., Manuel, I., Rodríguez‐Puertas, R., & Ugedo, L. (2010) · Synapse · doi:10.1002/syn.20778 · Cited by 9
“Among the endogenous ligands for CB1 receptors, anandamide is the best characterized (Devane et al., 1992; Di Marzo et al., 2004; Dowie et al., 2009; Freund et al., 2003; Piomelli and Di Marzo, 2003).”
BackgroundChemoproteomics identifies protein ligands for monoacylglycerol lipids
Shanbhag, K., Mhetre, A. B., Saharan, O., Devarajan, A., Rai, A., Madhusudhan, M. S., Chakrapani, H., & Kamat, S. S. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01589-w · Cited by 8
“Examples of such well-studied signaling lipids include prostaglandins 4 – 6 , endocannabinoids 7 – 10 , and a few classes of lysophospholipids such as sphingosine 1-phosphate 11 – 15 , lyso-phosphatidic acid 16 – 19 and lysophosphatidylserine 20,21 .”
Baldasso, G. M., Paes, R. S., Moreira, A. F., Salvadori, S. G., Limberger, C., Roviezzo, F., Capasso, R., & Dutra, R. C. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108185 · Cited by 8
Szkopek, D., Mendel, M., Kinsner, M., Fotschki, B., Juśkiewicz, J., Kozłowski, K., Matusevičius, P., & Konieczka, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111398 · Cited by 8
Conti, F., Lazzara, F., Thermos, K., Zingale, E., Spyridakos, D., Romano, G. L., Martino, S. D., Micale, V., Kuchař, M., Spadaro, A., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177323 · Cited by 8
Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
Kitchigina, V. F. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01148-5 · Cited by 8
Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins
Sommano, S. R., Sunanta, P., Leksawasdi, N., Jantanasakulwong, K., Rachtanapun, P., Seesuriyachan, P., Phimolsiripol, Y., Sringarm, K., Ruksiriwanich, W., Jantrawut, P., et al. (2022) · Molecules · doi:10.3390/molecules27103301 · Cited by 8
“Shortly after the recoveries of the cannabinoids, the cannabinoid receptors (CB1 and CB2) were identified and many endogenous ligands for the cannabinoid receptors were also recognised [11].”
BackgroundBárcena, A. D., & Giraldo, P. (2023) · Industrial Crops and Products · doi:10.1016/j.indcrop.2023.117143 · Cited by 8
4D-QSAR studies of CB2 cannabinoid receptor inverse agonists: a comparison to 3D-QSAR
Zhang, H., Lv, Q., Xu, W., Lai, X., Liu, Y., & Tu, G.-G. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02303-x · Cited by 8
Oza, M., Becker, W., Gummadidala, P. M., Dias, T., Omebeyinje, M. H., Chen, L., Mitra, C., Jesmin, R., Chakraborty, P., Sajish, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46478-0 · Cited by 8
Fluorescent triazolyl spirooxazolidines: Synthesis and NMR stereochemical studies
Kasza, P., Trybula, M. E., Baradziej, K., Kępczyński, M., Szafrański, P. W., & Cegla, M. T. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.01.052 · Cited by 8
Brain endocannabinoid system is involved in fluoxetine-induced anorexia
Sesma, J. Z., Churruca, I., Pascual, J., Casis, L., Sallés, J., & Echevarría, E. (2008) · Nutritional Neuroscience · doi:10.1179/147683008x301496 · Cited by 8
González‐Muniesa, P., Bing, C., & Trayhurn, P. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1255119 · Cited by 8
6 Recent Progress in Cannabinoid Research
Adam, J., Cowley, P. M., Kiyoi, T., Morrison, A. J., & Mort, C. (2006) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(05)44406-9 · Cited by 8
Cannabinoides endógenos en la enfermedad hepática: muchos dardos para una sola diana
Reichenbach, V., Ros, J., & Jiménez, W. (2009) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2009.06.010 · Cited by 8
Endocannabinoids and Their Synthetic Analogs
Vemuri, K. V., & Makriyannis, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_2 · Cited by 8
“Additionally, the ECS encompasses a family of membrane phospholipid-derived endogenous ligands known as endocannabinoids, and a number of functional proteins involved in the synthesis, transport, and inactivation of these endogenous ligands [9–11].”
BackgroundThe Endocannabinoid System and its Manifold Central Actions
Maccarrone, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_16 · Cited by 8
Safety and efficacy of hemp products in broiler production
Rasool, U. (2018) · Mspace (University of Manitoba) · Cited by 8
The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine
Urreola, G., Le, M. N., Harris, A., Castillo, J. A., Saiz, A. M., Shahzad, H., Martin, A. R., Kim, K. D., Khan, S. N., & Price, R. L. (2025) · Biomedicines · doi:10.3390/biomedicines13081891 · Cited by 7
Novel therapeutics in autism spectrum disorder
Kevelson, S. D., Elmaghraby, R., Patel, F., Brown, H. R., Gorenstein, M., Bain, J., Grinspan, Z. M., Pedapati, E. V., Veenstra-VanderWeele, J. M., & Vandana, P. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00857 · Cited by 7
Sobieraj, J., Strzelecka, K., Sobczak, M., & Olędzka, E. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s458907 · Cited by 7
“107 Both clinical and preclinical studies have reported the presence of a daily rhythm in the levels of endocannabinoids circulating in the body.”
BackgroundEndocannabinoids: biology, mechanism of action and functions
Sharkey, K. A. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803270 · Cited by 7
Farahmandfar, M., Kadivar, M., Naghdi, N., Choopani, S., & Zarrindast, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.054 · Cited by 7
Cannabinoid receptor 1 (CB1R) expression in rat dental pulp
Mitrirattanakul, S., Poomsawat, S., & Fuangtharnthip, P. (2012) · Oral Science International · doi:10.1016/s1348-8643(12)00003-1 · Cited by 7
Teixeira-Clerc, F., Julien, B., Grenard, P., Nhieu, J. T. V., Deveaux, V., Li, L., Serrière-Lanneau, V., Ledent, C. A., Mallat, A., & Lotersztajn, S. (2006) · médecine/sciences · doi:10.1051/medsci/20062289683 · Cited by 7
Allsop, D. J., Rooney, K. B., Arnold, J. C., Bhardwaj, A. K., Bruno, R., Bartlett, D. J., Montebello, M. E., Arkell, T. R., Richards, E., Gugusheff, J., et al. (2017) · Mental health and physical activity · doi:10.1016/j.mhpa.2017.06.002 · Cited by 7
Nemery, E., Gabriel, A., Piret, J., & Antoine, N. (2019) · Acta veterinaria Scandinavica · doi:10.1186/s13028-019-0439-3 · Cited by 7
Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management
Kibret, B. G., Patel, S. A., Niezgoda, J., Guns, W. M., Niezgoda, J., Gopalakrishnan, S., Baban, B., Cubillos, P., Villeneuve, D. M., & Kumar, P. (2022) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000831920.15801.25 · Cited by 7
Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2
Bouma, J., Soethoudt, M., van Gils, N., Xia, L., van der Stelt, M., & Heitman, L. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_15 · Cited by 7
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_144-1 · Cited by 7
Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP
Suter, T. M., Chesterfield, A. K., Bao, C., Schaus, J. M., Krushinski, J. H., Statnick, M. A., & Felder, C. C. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.055 · Cited by 7
Kabakchieva, P., GATEVA, A., Velikova, T. V., Georgiev, T., & KAMENOV, Z. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03336-4 · Cited by 7
Kojima, M., Kato, N., Hirano, D., Ochi, T., Nii, A., Shinjo, K., & Eda, H. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00473.x · Cited by 7
High-Density Lipoprotein Cholesterol
Gotto, P. P. T. A. A. M. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-14 · Cited by 7
Davis, S. N., & Perkins, J. M. (2007) · Endocrine Practice · doi:10.4158/ep.13.7.790 · Cited by 7
The Endocannabinoid System as a Therapeutic Target in Epilepsy
Monory, K., & Lutz, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_20 · Cited by 7
Endocannabinoid Role in Synaptic Plasticity and Learning
Lutz, B., & Marsicano, G. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00816-0 · Cited by 7
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Hasbi, A., & George, S. R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.100498 · Cited by 6
Thapa, D., Ghimire, A., Warne, L. N., & Carlessi, R. (2025) · Pharmaceuticals · doi:10.3390/ph18040478 · Cited by 6
“Core components of eCBome include the canonical cannabinoid receptors CB1 and CB2, key endocannabinoids (eCBs) such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and their metabolizing enzymes, fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) [14,15].”
Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
Krauze, I., Greb‐Markiewicz, B., Kłopot, A., Maciejewska, K., Bryk, M., & Krzystek‐Korpacka, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1595913 · Cited by 6
“…that the ECS primarily regulated the nervous system; however, subsequent research has elucidated its role in governing key physiological processes such as anxiety, appetite regulation, the reward system, pain perception, fertility, immune system, and numerous other vital functions (91, 92).”
Metadata
- Authors
- Marzo, V. D., Bifulco, M., & Petrocellis, L. D.
- Affiliations
- Istituto di Chimica Biomolecolare (IT)
- Institute of Applied Science and Intelligent Systems (IT)
- University of Salerno (IT)
- Corresponding author
- Marzo, Vincenzo Di
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-09-01
- Volume
- 3
- Issue
- 9
- Pages
- 771-784
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2087674201
- Cited by
- 1,090
- References
- 161
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 61 · 2023: 48 · 2022: 43 · 2021: 44 · 2020: 49 · 2019: 43 · 2018: 35 · 2017: 41 · 2016: 28 · 2015: 42 · 2014: 38 · 2013: 48 · 2012: 42
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- endocannabinoid system, cannabinoid receptors, cannabinoid therapeutics, drug development, pathological conditions
- MeSH terms
- Animals, Cannabinoids, Cannabis, Clinical Trials as Topic, Enzymes, Humans, Drug Design, Signal Transduction, Receptors, Cannabinoid, Cannabinoid Receptor Modulators, Cannabinoid Receptor Agonists, Cannabinoid Receptor Antagonists, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.